DE3773387D1 - Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. - Google Patents
Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.Info
- Publication number
- DE3773387D1 DE3773387D1 DE8787903945T DE3773387T DE3773387D1 DE 3773387 D1 DE3773387 D1 DE 3773387D1 DE 8787903945 T DE8787903945 T DE 8787903945T DE 3773387 T DE3773387 T DE 3773387T DE 3773387 D1 DE3773387 D1 DE 3773387D1
- Authority
- DE
- Germany
- Prior art keywords
- diseases
- agents
- treatment
- combination
- gamma interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87540186A | 1986-06-17 | 1986-06-17 | |
PCT/US1987/001228 WO1987007842A1 (en) | 1986-06-17 | 1987-06-01 | Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3773387D1 true DE3773387D1 (de) | 1991-10-31 |
Family
ID=25365733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787903945T Revoked DE3773387D1 (de) | 1986-06-17 | 1987-06-01 | Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0311616B1 (de) |
JP (1) | JPH01502980A (de) |
AT (1) | ATE67675T1 (de) |
DE (1) | DE3773387D1 (de) |
WO (1) | WO1987007842A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200177A (en) * | 1989-12-01 | 1993-04-06 | The Children's Medical Center Corporation | Treatment of atopic disorders with gamma-interferon |
JP2901017B2 (ja) * | 1989-12-01 | 1999-06-02 | チルドレンズ・メデイカル・センター・コーポレーシヨン | γインターフエロンによるアトピー性疾患の処置 |
ES2137981T3 (es) * | 1991-11-19 | 2000-01-01 | Univ Virginia | Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes. |
US5266312A (en) * | 1992-01-07 | 1993-11-30 | National Jewis Center For Immunology And Respiratory Medicine | Method for treating a steroid resistant condition via administration of gamma interferon |
GB2293323A (en) * | 1994-09-12 | 1996-03-27 | Orion Yhtymae Oy | Antibiotics and bismuth salts for treating bacterial infections |
CA2200084C (en) * | 1994-09-16 | 2007-03-27 | Jose Halperin | Use of aromatic halides for treating mammalian cell proliferation |
EP0800828A4 (de) * | 1994-12-28 | 1999-03-31 | Teikoku Hormone Mfg Co Ltd | Transmucosale zubereitung |
GB2304342A (en) * | 1995-08-18 | 1997-03-19 | Univ Manchester | Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma |
EP0795332B1 (de) * | 1996-03-14 | 2005-06-01 | Mondobiotech Interferon SA | Medizinische Verwendung von Gamma-Interferon im interstitiellen Lungenerkrankungen |
US6299871B1 (en) * | 1998-07-24 | 2001-10-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases |
CA2387089A1 (en) * | 1999-11-10 | 2001-05-17 | Mondobiotech Sa | Interferon gamma for the treatment of asthma |
GB0518558D0 (en) * | 2005-09-12 | 2005-10-19 | Givaudan Sa | Improvements in or related to organic compounds |
FR2958849A1 (fr) * | 2010-04-14 | 2011-10-21 | Boiron | Medicament homeopathique a activite anti-cancereuse |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4252797A (en) * | 1979-07-19 | 1981-02-24 | Walter Rosenthal | Corticosteroid calcium compositions and treatment of rheumatic diseases therewith |
US4246263A (en) * | 1979-10-15 | 1981-01-20 | Pfizer Inc. | Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions |
US4390545A (en) * | 1981-11-19 | 1983-06-28 | American Cyanamid Company | Combinations of agents which give enhanced anti-inflammatory activity |
EP0177342A3 (de) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Orale Formulierungen therapeutischer Proteine |
IL76591A0 (en) * | 1984-10-05 | 1986-02-28 | Bioferon Biochem Substanz | Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof |
DE3436638C2 (de) * | 1984-10-05 | 1992-10-08 | Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim | Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen |
-
1987
- 1987-06-01 EP EP87903945A patent/EP0311616B1/de not_active Expired - Lifetime
- 1987-06-01 WO PCT/US1987/001228 patent/WO1987007842A1/en not_active Application Discontinuation
- 1987-06-01 JP JP62503620A patent/JPH01502980A/ja active Pending
- 1987-06-01 AT AT87903945T patent/ATE67675T1/de not_active IP Right Cessation
- 1987-06-01 DE DE8787903945T patent/DE3773387D1/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
EP0311616A1 (de) | 1989-04-19 |
EP0311616B1 (de) | 1991-09-25 |
EP0311616A4 (de) | 1989-05-23 |
JPH01502980A (ja) | 1989-10-12 |
ATE67675T1 (de) | 1991-10-15 |
WO1987007842A1 (en) | 1987-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE126441T1 (de) | Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen. | |
DE3773387D1 (de) | Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. | |
ATE277612T1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE69229050T2 (de) | Verwendung von Papillomavirusprotein L2 zur therapeutischen Behandlung von durch Papillomavirus hervorgerufenen Tumoren oder oder anderen krankhaften Veränderungen | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
FI844510L (fi) | Ensym-resistenta immunsystemet modulerande peptider. | |
DK467487A (da) | Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis | |
ATE286510T1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
ATE120372T1 (de) | Antikörper für die antilymphozyten- antikörpertherapie. | |
DE59407414D1 (de) | Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha | |
NO964238L (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
DE3850433D1 (de) | Allergiebehandlung und Zusammensetzung dafür. | |
DE69429101T2 (de) | Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen | |
NO931413D0 (no) | Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer | |
ATE17480T1 (de) | Entzuendungshemmende und/oder schmerzstillende 2,3-diaryl-5-halo thiophene. | |
DE3679781D1 (de) | Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung. | |
ATE86492T1 (de) | Anwendung von sterolinen und spiroketalinen zur herstellung von medikamenten zur behandlung von psoriasis. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
DE3674619D1 (de) | Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis. | |
ATE238795T1 (de) | Verwendung von aminothiazolen zur wund- und hautbehandlung | |
GB8327598D0 (en) | Pharmacologically active diarylindane-13-diones | |
ATE74755T1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
DE69117566D1 (de) | Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |